
TY  - JOUR
TI  - POSTERS
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 19
IS  - s2
SN  - 0926-9959
UR  - https://doi.org/10.1111/j.1468-3083.2005.01311.x
DO  - doi:10.1111/j.1468-3083.2005.01311.x
SP  - 1
EP  - 411
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Vox Sanguinis
JA  - Vox Sang
VL  - 112
IS  - S2
SN  - 0042-9007
UR  - https://doi.org/10.1111/vox.12601
DO  - doi:10.1111/vox.12601
SP  - 5
EP  - 191
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - British Journal of Haematology
JA  - Br J Haematol
VL  - 181
IS  - S1
SN  - 0007-1048
UR  - https://doi.org/10.1111/bjh.15226
DO  - doi:10.1111/bjh.15226
SP  - 5
EP  - 211
PY  - 2018
ER  - 

TY  - JOUR
TI  - Oral Presentations
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 7
IS  - s2
SN  - 0926-9959
UR  - https://doi.org/10.1111/j.1468-3083.1996.tb00603.x
DO  - doi:10.1111/j.1468-3083.1996.tb00603.x
SP  - s61
EP  - s124
PY  - 1996
ER  - 

TY  - JOUR
TI  - Abstracts presented at the 49th Annual Meeting of the American Society of Dermatopathology October 11-14,2012 Chicago, Illinois USA
JO  - Journal of Cutaneous Pathology
JA  - J Cutan Pathol
VL  - 40
IS  - 1
SN  - 0303-6987
UR  - https://doi.org/10.1111/cup.12062
DO  - doi:10.1111/cup.12062
SP  - 70
EP  - 201
PY  - 2013
ER  - 

TY  - JOUR
TI  - 2013 Meeting of the Peripheral Nerve Society, June 29–July 3, 2013, Saint–Malo, France
JO  - Journal of the Peripheral Nervous System
JA  - J Peripher Nerv Syst
VL  - 18
IS  - s2
SN  - 1085-9489
UR  - https://doi.org/10.1111/jns5.12025
DO  - doi:10.1111/jns5.12025
SP  - 1
EP  - 131
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts of papers,** Ninety-fourth Annual Meeting, The Hilton Hawaiian Village Honolulu, Hawaii, March 24–26, 1993
JO  - Clinical Pharmacology & Therapeutics
JA  - Clinical Pharmacology & Therapeutics
VL  - 53
IS  - 2
SN  - 0009-9236
UR  - https://doi.org/10.1038/clpt.1993.20
DO  - doi:10.1038/clpt.1993.20
SP  - 135
EP  - 241
PY  - 1993
AB  - Clinical Pharmacology and Therapeutics (1993) 53, 135?241; doi:10.1038/clpt.1993.20
ER  - 

TY  - JOUR
TI  - COSM Preliminary Programs
JO  - The Laryngoscope
VL  - 101
IS  - 4
SN  - 0023-852X
UR  - https://doi.org/10.1002/lary.1991.101.4.439
DO  - doi:10.1002/lary.1991.101.4.439
SP  - 439
EP  - 450
PY  - 1991
ER  - 

TY  - JOUR
TI  - Poster Session Group II – Red TPS 20
JO  - Allergy
JA  - Allergy
VL  - 70
IS  - S101
SN  - 0105-4538
UR  - https://doi.org/10.1111/all.12720
DO  - doi:10.1111/all.12720
SP  - 409
EP  - 506
PY  - 2015
ER  - 

TY  - JOUR
TI  - 2015 Peripheral Nerve Society Biennial Meeting
JO  - Journal of the Peripheral Nervous System
JA  - J Peripher Nerv Syst
VL  - 20
IS  - 2
SN  - 1085-9489
UR  - https://doi.org/10.1111/jns.12129
DO  - doi:10.1111/jns.12129
SP  - 88
EP  - 253
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Pain Practice
JA  - Pain Pract
VL  - 16
IS  - S1
SN  - 1530-7085
UR  - https://doi.org/10.1111/papr.12451
DO  - doi:10.1111/papr.12451
SP  - 6
EP  - 176
PY  - 2016
ER  - 

TY  - JOUR
AU  - Caers, Jo
AU  - Vande broek, Isabelle
AU  - De Raeve, Hendrik
AU  - Michaux, Lucienne
AU  - Trullemans, Fabienne
AU  - Schots, Rik
AU  - Van Camp, Ben
AU  - Vanderkerken, Karin
TI  - Multiple myeloma – an update on diagnosis and treatment
JO  - European Journal of Haematology
VL  - 81
IS  - 5
SN  - 0902-4441
UR  - https://doi.org/10.1111/j.1600-0609.2008.01127.x
DO  - doi:10.1111/j.1600-0609.2008.01127.x
SP  - 329
EP  - 343
KW  - multiple myeloma
KW  - management
KW  - risk stratification
PY  - 2008
AB  - Abstract Multiple myeloma is a plasma cell (PC) malignancy characterized by the accumulation of monoclonal PCs in the bone marrow and the production of large amounts of a monoclonal immunoglobulin or paraprotein. In the past years, new approaches in the diagnosis and treatment were introduced aiming to identify high-risk patients who need proper anti-myeloma treatment. Intensive therapy including autologous hematopoietic stem cell transplantation and the new agents bortezomib, thalidomide, and lenalidomide have improved patients? responses. Further optimalization of the different treatment schedules in well-defined patient groups may prolong their survival. Patient stratification is currently based on patient characteristics, extent of myeloma disease, and associated cytogenetic and laboratory anomalies. More and more gene expression studies are introduced to stratify patients and to individualize therapy.
ER  - 

TY  - JOUR
TI  - Posters Abstracts
JO  - Research and Practice in Thrombosis and Haemostasis
JA  - Res Pract Thromb Haemost
VL  - 3
IS  - S1
SN  - 2475-0328
UR  - https://doi.org/10.1002/rth2.12229
DO  - doi:10.1002/rth2.12229
SP  - 1
EP  - 891
PY  - 2019
ER  - 

TY  - JOUR
TI  - Scientific Abstracts and Sessions
JO  - Medical Physics
JA  - Med. Phys.
VL  - 46
IS  - 6
SN  - 0094-2405
UR  - https://doi.org/10.1002/mp.13589
DO  - doi:10.1002/mp.13589
SP  - e94
EP  - e670
PY  - 2019
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Journal of the American Geriatrics Society
VL  - 48
IS  - 8
SN  - 0002-8614
UR  - https://doi.org/10.1111/j.1532-5415.2000.tb06881.x
DO  - doi:10.1111/j.1532-5415.2000.tb06881.x
SP  - S12
EP  - S135
PY  - 2000
ER  - 

TY  - JOUR
TI  - WORLD TRANSPLANT CONGRESS 2006 POSTER ABSTRACTS
JO  - American Journal of Transplantation
VL  - 6
IS  - s2
SN  - 1600-6135
UR  - https://doi.org/10.1111/j.1600-6143.2006.01447.x
DO  - doi:10.1111/j.1600-6143.2006.01447.x
SP  - 473
EP  - 1061
PY  - 2006
ER  - 

TY  - JOUR
TI  - Earn contact hours at Congress by viewing poster displays
JO  - AORN Journal
JA  - AORN Journal
VL  - 79
IS  - 2
SN  - 0001-2092
UR  - https://doi.org/10.1016/S0001-2092(06)60608-X
DO  - doi:10.1016/S0001-2092(06)60608-X
SP  - 312
EP  - 328
PY  - 2004
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Research and Practice in Thrombosis and Haemostasis
JA  - Res Pract Thromb Haemost
VL  - 2
IS  - S1
SN  - 2475-0328
UR  - https://doi.org/10.1002/rth2.12125
DO  - doi:10.1002/rth2.12125
SP  - 1
EP  - 368
PY  - 2018
ER  - 

TY  - JOUR
AU  - Renella, Raffaele
AU  - Schaefer, Elke
AU  - LeMerrer, Martine
AU  - Alanay, Yasemin
AU  - Kandemir, Nurgun
AU  - Eich, Georg
AU  - Costa, Teresa
AU  - Ballhausen, Diana
AU  - Boltshauser, Eugen
AU  - Bonafé, Luisa
AU  - Giedion, Andres
AU  - Unger, Sheila
AU  - Superti-Furga, Andrea
TI  - Spondyloenchondrodysplasia with spasticity, cerebral calcifications, and immune dysregulation: Clinical and radiographic delineation of a pleiotropic disorder
JO  - American Journal of Medical Genetics Part A
JA  - Am. J. Med. Genet.
VL  - 140A
IS  - 6
SN  - 1552-4825
UR  - https://doi.org/10.1002/ajmg.a.31081
DO  - doi:10.1002/ajmg.a.31081
SP  - 541
EP  - 550
KW  - spondyloenchondrodysplasia
KW  - skeletal dysplasia
KW  - enchondroma
KW  - spasticity
KW  - cerebral calcification
KW  - immune dysregulation
KW  - immunodeficiency
PY  - 2006
AB  - Abstract Enchondromas are a feature of several constitutional disorders of bone, and the classification of different nosologic entities is still provisional. Among these disorders, spondyloenchondrodysplasia (SPENCD), as outlined by Schorr et al. [1976], is defined by the presence of radiolucent spondylar and metaphyseal lesions that represent persistence of islands of chondroid tissue within bone. Careful review of radiographic findings is needed to distinguish SPENCD from the many other disorders combining enchondromas with spinal lesions. Even when strict criteria are applied, it appears that SPENCD is clinically heterogeneous, as some SPENCD patients are neurologically intact while others present with spasticity, mental retardation, and cerebral calcifications in different combinations, and it has been suggested that SPENCD should be divided in two types. We herein report ten individuals from six families with SPENCD and illustrate the radiographic changes. Seven individuals had CNS manifestations including spasticity, developmental delay, and late-onset cerebral calcifications. We also noted that six individuals had clinical manifestations of autoimmunity (auto-immune thrombocytopenic purpura, auto-immune hemolytic anemia, auto-immune thyroiditis, and SLE) and one had been diagnosed with immune deficiency. Neurological and autoimmune manifestations were seen in different combinations within one single family. These observations suggest that SPENCD may be a single entity defined by specific radiographic features, but with remarkably pleiotropic manifestations that include CNS disease (spasticity, mental retardation, and calcifications), as well as immune dysregulation ranging from autoimmunity to immunodeficiency. The notion of recessive inheritance hitherto assumed is challenged by the observation of two apparently dominant pedigrees. ? 2006 Wiley-Liss, Inc.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Alcoholism: Clinical and Experimental Research
VL  - 14
IS  - 2
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.1990.tb00486.x
DO  - doi:10.1111/j.1530-0277.1990.tb00486.x
SP  - 264
EP  - 356
PY  - 1990
ER  - 
